Lenardo; Michael J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lenardo; Michael J..The latest application filed is for "myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of use".

Company Profile

3.12.9

Lenardo; Michael J. - Bethesda MD
Lenardo; Michael J. - Potomac MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, And Proteolipid Protein Compositions And Methods Of Use App 20210038685 - Lenardo; Michael J. ; et al.	2021-02-11
Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of use Grant 10,759,838 - Lenardo , et al. Sep	2020-09-01
Methods Of Diagnosing And Treating Cd55 Deficiency, Hyperactivation Of Complement, Angiopathic Thrombosis And Protein Losing Ent App 20190256915 - Lenardo; Michael J. ; et al.	2019-08-22
Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, And Proteolipid Protein Compositions And Methods Of Use App 20180105566 - Lenardo; Michael J. ; et al.	2018-04-19
Inhibitors of pre-ligand assembly doman and function of the tumor necrosis factor receptor family Grant 9,051,392 - Lenardo , et al. June 9, 2	2015-06-09
Function of autophagy genes in cell death Grant 7,838,645 - Baehrecke , et al. November 23, 2	2010-11-23
Identification of a novel domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and function App 20070190607 - Lenardo; Michael J. ; et al.	2007-08-16
Identification of a novel domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and function Grant 7,148,061 - Lenardo , et al. December 12, 2	2006-12-12
Modified myelin basic protein molecules Grant 7,041,503 - Nye , et al. May 9, 2	2006-05-09
Nuclear factors associated with transcriptional regulation App 20060063709 - Baltimore; David ; et al.	2006-03-23
Function of autophagy genes in cell death App 20050276809 - Baehrecke, Eric H. ; et al.	2005-12-15
Nuclear factors associated with transcriptional regulation App 20040214757 - Baltimore, David ; et al.	2004-10-28
Modified Myelin Basic Protein Molecules App 20040180808 - NYE, STEVEN H. ; et al.	2004-09-16
Identification of a novel domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and function App 20030108992 - Lenardo, Michael J. ; et al.	2003-06-12
Nuclear factors associated with transcriptional regulation Grant 6,410,516 - Baltimore , et al. June 25, 2	2002-06-25
Nuclear factors associated with transcriptional regulation Grant 6,150,090 - Baltimore , et al. November 21, 2	2000-11-21
Interleukin-2 stimulated T lymphocyte cell death for the treatment of autoimmune diseases, allergic responses, and graft rejection Grant 6,083,503 - Lenardo July 4, 2	2000-07-04
Interleukin-2 stimulated T lymphocyte cell death for the treatment of allergic responses Grant 5,989,546 - Lenardo November 23, 1	1999-11-23
Interleukin-4 stimulated T lymphocyte cell death for the treatment of allergic disorders Grant 5,935,575 - Lenardo , et al. August 10, 1	1999-08-10
Nuclear factors associates with transcriptional regulation Grant 5,804,374 - Baltimore , et al. September 8, 1	1998-09-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.